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Abstract
Background Cancer cachexia is a complex syndrome relat-
ed to a negative energy balance resulting in muscle wasting.
Implication of muscle mitochondrial bioenergetics altera-
tions during cancer cachexia was suggested. Therefore, the
aim of this study was to explore the efficiency of oxidative
phosphorylation in skeletal muscle mitochondria in a pre-
clinical model of cancer cachexia.
Methods Berlin–Druckrey IX rats with peritoneal carcinosis
(PC) were used as a model of cancer cachexia with healthy
pair-fed rats (PF) as control. Hindlimb muscle morphology
and fibre type composition were analysed in parallel
with ubiquitin ligases and UCP gene expression. Oxida-
tive phosphorylation was investigated in isolated muscle
mitochondria by measuring oxygen consumption and
ATP synthesis rate.
Results PC rats underwent significant muscle wasting af-
fecting fast glycolytic muscles due to a reduction in fibre
cross-sectional area. MuRF1 and MAFbx gene expression
were significantly increased (9- and 3.5-fold, respectively)
in the muscle of PC compared to PF rats. Oxygen consump-
tion in non-phosphorylating state and the ATP/O were sim-
ilar in both groups. Muscle UCP2 gene was overexpressed
in PC rats. State III and the uncoupled state were signifi-
cantly lower in muscle mitochondria from PC rats with a
parallel reduction in complex IV activity (−30 %).
Conclusion This study demonstrated that there was neither
alteration in ATP synthesis efficiency nor mitochondrial
uncoupling in skeletal muscle of cachectic rats despite
UCP2 gene overexpression. Muscle mitochondrial oxidative
capacities were reduced due to a decrease in complex IV
activity. This mitochondrial bioenergetics alteration could
participate to insulin resistance, lipid droplet accumulation
and lactate production.
Keywords Muscle atrophy . PROb-BDIXmodel . Energy
wasting . Cardiolipin . UCP . COX IV
1 Introduction
Cancer cachexia is a complex syndrome that encompasses a
wide range of metabolic, hormonal and cytokine-related
abnormalities leading to a negative energy balance due to
both anorexia and hypermetabolism resulting in a wasting
syndrome. The accelerated breakdown of muscle and adi-
pose tissues providing substrates to the host and the tumour
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is responsible for the depletion of lipid and protein stores
and account for most of the weight loss [1]. Skeletal muscle
atrophy is a major factor involved in cancer cachexia since it
contributes to physical disability, weakness and decreased
capacity of wound healing and reduces responsiveness to
chemotherapy. Skeletal muscle loss in cancer cachexia is
due to fibre atrophy, which seems to affect predominantly
glycolytic fibres [2, 3]. Research efforts have led to better
understanding of the molecular and signalling mechanisms
responsible for skeletal muscle atrophy in cancer cachexia.
Studies in animals [4] as well as in humans [5] emphasise
the ubiquitin–proteasome pathway as the main mechanism
for myofibrillar protein degradation. Muscle atrophy F box
(MAFbx)/atrogin 1 and muscle RING finger 1 (MuRF1),
muscle-specific E3 ligases with function in protein ubiquiti-
nation, have been shown to mediate proteosome-dependent
protein degradation in cancer cachexia [4, 6]. The ubiquitin–
proteasome-dependent proteolysis is an ATP requiring pro-
cess. Therefore, we can logically wonder how muscle mito-
chondria deals with these high energy needs for proteolysis
in cancer cachexia. The mitochondrial respiratory chain
ATP synthesis by the F1F0ATP synthase is coupled to oxy-
gen consumption (oxidation). The coupling of the oxidative
phosphorylation is modulated in order to maintain energy
homeostasis with a compromise between the rate and effi-
ciency of ATP synthesis. During high energy demand, the
cost for a high rate of ATP synthesis in mitochondria is a
decreased efficiency. These processes represent energy
wasting since all oxygen consumed will not be converted
into ATP [7, 8]. In this way, we can hypothesise that in a
situation of high muscle proteolysis as in cancer cachexia,
muscle mitochondria could be the place of energy wasting.
If energy wasting (reduction in ATP production efficiency)
is occurring in skeletal muscle mitochondria, it could par-
ticipate significantly to cancer cachexia by increasing ener-
gy expenditure since skeletal muscle accounts for 15 to
30 % of the basal energy expenditure [9].
Pioneer indirect evidences for a reduction in oxidative
phosphorylation efficiency in skeletal muscle mitochondria
in cancer cachexia came from studies reporting uncoupling
protein 2 and 3 (UCP) genes overexpression in skeletal
muscle in animal model of cancer cachexia [10–15] as well
as in patients with cancer [16], or other wasting diseases
[17]. Overexpression of UCP2 and UCP3 were considered
by these authors as possibly associated to mitochondrial
uncoupling, but never experimentally proven. Recently,
Constantinou and collaborators [15], using in vivo 31P nu-
clear magnetic resonance, published interesting data rein-
forcing the idea that muscle energy production capacities are
affected in cancer cachexia. Indeed, skeletal muscle ATP
synthesis rate was significantly reduced in mouse model of
cancer cachexia. However, to our knowledge, only one
study has investigated muscle mitochondrial respiratory
chain function in a rat cancer cachexia model [18].
Ushmorov and co-workers found a reduction in oxygen
consumption in phosphorylating state (with ATP synthe-
sis) in isolated skeletal muscle mitochondria but data on
ATP synthesis efficiency and energy wasting were lack-
ing. Another recent study reported a reduction in cyto-
chrome c oxidase IV (COX IV) protein expression in skeletal
muscle of ApcMin/+ cachectic mice [19]. Despite these indi-
rect evidences and arguments, efficiency of skeletal muscle
mitochondrial oxidative phosphorylation in cancer cachexia is
still unexplored while it can significantly affect energy bal-
ance. Therefore, the aim of this study was to determine if
efficiency of oxidative phosphorylation is impaired in skeletal
muscle mitochondria in a preclinical model of cancer cachexia
in rats.
2 Experimental procedures
2.1 Animal care and experimental design
The present investigation received the agreement of the
French Ethic Committee ‘Region Centre’ and was per-
formed in accordance with the French guiding principles
in the care and use of animals. Twenty healthy immuno-
competent male Berlin–Druckrey IX (BDIX) rats were sup-
plied by Charles River laboratories (L’Arbresle, France) at
8 weeks of age (195±2 g). After arrival, the rats were
housed three per cage and were fed ad libitum and weighed
weekly.
We used the PROb-BDIX model of cancer cachexia as
described previously [20]. At 9 weeks of age, rats were
individually housed and acclimated for 2 weeks. During this
period, body weight and food intake were measured every
2 days. Then, rats were divided into three groups as follows:
(1) one fed ad libitum with tumour inoculation (peritoneal
carcinosis, PC; n010) that received a single IP injection of
106 of PROb cells in 1 ml of RPMI 1640 medium [20], (2)
one healthy group fed ad libitum that received an IP injec-
tion of 1 ml of RPMI 1640 medium without tumour inocu-
lation (Hal; n010) and (3) one healthy group pair-fed to PC
rats (PF, n010). PF rats, weight-matched to PC rats, re-
ceived an IP injection of 1 ml of RPMI 1640 medium
without tumour inoculation. The use of a pair-fed group as
control allowed us to discriminate between the effects of
anorexia and hypermetabolism related to cancer cachexia on
the parameters measured in this study. The amount of food
for the PF rats was based on the food intake measured every
2 days in PC rats until sacrifice (each PC rat was paired with
a PF rat).
As we described previously (for details, see [20] and
[21]), when PC rats reached severe cachexia state (sacrifice
time), food intake was significantly reduced (severe
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anorexia, −75±4 % of reduction in comparison to Hal rats).
Food intake reduction was progressive during peritoneal
carcinosis development and became statistically significant
from 24 days after cancer induction (−20 %) until sacrifice
(35 days after cancer induction) (−75±4 %).
Body weight (ascites free) of PC rats at sacrifice was
significantly lower than in Hal (305±29 vs 378±28 g, re-
spectively) and PF rats (332±21 g) (results published in
[20]). Moreover, body weight of PF rats at sacrifice time
was significantly lower than in the Hal group [20]. Overall
body weight gain was drastically reduced in PC compared to
PF rats (0.02 vs 0.1 g/day/100 g of body weight, respective-
ly [20]). At this advanced state of cancer cachexia, TNFα
level in serum was higher in PC than in Hal and PF rats (14-
and 27-fold. respectively) with a similar level between Hal
and PF rats [20].
2.2 Tissue collection
Each PF rat was euthanised 2 days after the paired PC rat, to
ensure adequate food restriction period. After blood and
ascites collection, muscles were rapidly removed and
weighed. The right quadriceps was immediately placed in
ice-cold isolation medium (sucrose 250 mM, EDTA 1 mM,
Tris/HCl 20 mM, pH 7.4) for mitochondrial preparation.
Intermediate vastus of the other quadriceps was frozen in
isopentane cooled by liquid nitrogen for later histological
analyses. Portions of quadriceps muscle were frozen for
RNA and other analyses. All samples were stored at −80°C
until analysis.
2.3 Quadriceps fibre type and morphometry
Serial cross sections (12 μm thick) of quadriceps mus-
cle were performed at −20°C using a cryostat micro-
tome. All staining procedures were performed according
to Remignon et al. [22]. Myofibrillar ATPase activities
were assessed after acidic and alkaline pre-incubation at
pH 4.35 and 9.40, respectively. Succinate dehydrogenase
activity was also evaluated. Fibres were classified as types I,
IIa, IIx and IIb according to the classification procedure de-
scribed by Lind and Kernell [23]. Fibre number by field and
fibre cross-sectional area (CSA) were determined on muscle
sections stained with azorubin. For each sample, mean CSA
was determined on approximately 150 fibres in two random
fields. All quantitative analyses were carried out by using a
computerised image analysis system (Visilog 4.0, Noesis,
Courtaboeuf, France).
2.4 Ubiquitin–proteasome pathway-related protein
and UCP2 and UCP3 gene expression
Total RNA was extracted using Trizol according to the
manufacturer’s recommendations. After RNase-Free DNase
treatment, RNA was reverse-transcribed using Super Script
II RNase H Reverse Transcriptase (Invitrogen, Carlsbad,
CA, USA) and random primers (Promega, Charbonnieres-
les-bains, France). Quantitative real-time RT-PCRs were
performed in duplicate using an ABI Prism 7000 apparatus
(Applied Biosystems, Foster City, CA, USA). The primers
chosen for studying the gene expression of two ubiquitin–
protein ligases ((E3) MuRF1 and atrogin 1/MAFbx) and
UCP2 and UCP3 were specifically designed and validated
(Table 1). All primers were obtained from Eurogentec SA
(Angers, France). The cycling conditions consisted in a
denaturation step (95°C for 10 min) and 35 cycles of am-
plification, including both denaturation for 15 s at 95°C and
annealing–extension for 1 min at 60°C (62°C for UCP2). At
the end of the PCR, dissociation was performed by slowly
heating the samples from 60 to 95°C and continuous record-
ing of the decrease in SYBR Green fluorescence resulting
from the dissociation of double-stranded DNA. Mean PCR
efficiency for each target gene was determined by
performing five to six serial dilutions of a cDNA pool.
The threshold cycle (Ct), defined as the cycle at which an
increase in fluorescence above a defined baseline can be
first detected, was determined for each sample. The mRNA
levels were estimated based on the Ct deviation of an
Table 1 Oligonucleotide primer
sequences used for qPCR
analysis
MAFbx Muscle Atrophy F box
or Atrogin 1, MuRF1 Muscle
RING Finger 1, UCP Uncou-
pling Protein 2 and 3
Gene Primers Product size (bp) Accession number
MuRF1 Forward: 5′GGT GCC TAC TTG CTC CTT GT3′ 203 AY059627.1
Reverse: 5′TCA CCT GGT GGC TGT TTT C3′
MAFbx Forward: 5′TTA TGC ACG CTG GTC CAG A3′ 170 NM_133521
Reverse: 5′TGT AAG CAC ACA GGC AGG TC3′
UCP2 Forward: 5′-ACA AGA CCA TTG CAC GAG AG-3′ 293 AF039033
Reverse: 5′-CAT GGT CAG GGC ACA GTG GC-3′
UCP3 Forward: 5′GTG ACC TAT GAC ATC ATC AAG GA3′ 89 NM_013167
Reverse: 5′GCT CCA AAG GCA GAG ACA AAG3′
β-Actin Forward: 5′CTG GCT CCT AGC ACC ATG AA3′ 103 NM_031144
Reverse: 5′CTG CTT GCT GAT CCA CAT CT5′
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unknown sample vs a control cDNA (consisting of a pool of
rat muscle cDNA) according to the equation proposed by
Pfaffl [24]. Beta-actin was chosen as the reference gene to
standardise data.
2.5 Preparation of mitochondria
At sacrifice time, muscle mitochondria were isolated by
differential centrifugation as previously described [25]. Af-
ter mincing, muscle was homogenised using a Potter-
Elvenhjem homogeniser (7 strokes) in isolation medium
with protease subtilisin A (1 mg/g of muscle). Then, the
homogenate was diluted two times and centrifuged at 800× g
for 10 min. The resulting supernatant was filtered and centri-
fuged at 10,000× g for 10 min. The pellet of muscle mito-
chondria was resuspended in isolation medium and then
centrifuged (10,000× g, 10 min). The resulting pellet was
resuspended in isolation medium and protein concentration
was determined using the bicinchoninic acid assay kit (Inter-
chim) with BSA used as a standard. After protein concentra-
tion determination, mitochondrial solution was supplemented
with 0.3 % (w/v) fatty acid-free BSA.
2.6 Mitochondria oxygen consumption
Oxygen was measured using a Clark oxygen electrode
(Hansatech, and Rank Brothers Ltd) as previously described
[25]. Mitochondria (0.2 mg/ml) were incubated at 37°C in a
respiratory reaction medium (KCl 120 mM, KH2PO4 5 mM,
EGTA 1 mM, MgCl2 2 mM, Hepes 3 mM, pH 7.4) saturated
with ambient air. Oxygen consumption rate was measured
with succinate (5 mM) as substrate in the presence of rote-
none (2.5 μM, complex I inhibitor). Next, oxygen consump-
tion in phosphorylating state (state III) was initiated by the
addition of ADP (300 μM). Then, oligomycin (2 μg/mg of
protein, inhibitor of ATP synthase) was added to measure
non-phosphorylating oxygen consumption rate (state IV).
Afterwards, the uncoupled state of oxygen consumption
was initiated by the addition of carbonyl cyanide p-
trifluoromethoxyphenylhydrazone (FCCP, 2 μM). The res-
piratory control ratio (RCR) refers to the ratio state III/state
IV. The integrity of isolated mitochondria was checked by
the addition of exogenous cytochrome c. A significant in-
crease in oxygen consumption after cytochrome c is an
index of damaged mitochondria.
2.7 Mitochondrial ATP synthesis
The rate of ATP synthesis was followed by glucose 6-
phosphate accumulation using an ADP regenerating system
based on hexokinase plus glucose and ATP as previously
described [21]. The respiratory reaction medium as de-
scribed above was supplemented with 5 mM succinate,
5 μM rotenone, 20 mM glucose and 125 μM ATP. ATP
synthesis was modulated by a sequential increase in hexo-
kinase concentration at 37°C. Glucose 6-phosphate for-
mation was monitored from NADPH content by
spectrophotometry at 340 nm.
2.8 Determination of cytochrome c oxidase protein
expression by western blotting
Equal amounts of quadriceps mitochondrial proteins
(5 μg) were boiled in the loading buffer and resolved
by 12.5 % SDS polyacrylamide gels. For immunoblot-
ting, proteins were transferred onto a polyvinylidene
difluoride membrane (Immobilon-P Transfer Membrane;
Millipore) with 3-(cyclohexylamino)-1-propane sulfonic
acid electroblotting buffer for 2 h at 150 mA. The blot
was blocked overnight in a blocking buffer (5 % non-fat
milk in phosphate-buffered saline solution, PBS),
washed three times in PBS–Tween 20 for 5 min and
probed for 2 h at room temperature with a monoclonal
antibody anti-complex IV (1:20,000; Mitosciences). The
blot was washed three times for 5 min in PBS–Tween
20 and probed for 1 h at room temperature with
peroxidase-conjugated goat anti-mouse IgG (1:3,000;
SouthernBiotech). Signals were visualised on high-
performance chemiluminescence film (Sigma) using an
enhanced chemiluminescence procedure (Amersham
France). The membranes were scanned and the signals
were analysed with Quantity One software (Bio-Rad).
2.9 Cytochrome c oxidase activity
COX activity was measured by spectrophotometry in isolated
quadriceps mitochondria (10 μg of protein) as previously
described [26].
2.10 Cardiolipin content
Cardiolipins were quantified by incubating (10 min, 37°C)
0.2 mg mitochondrial protein in 2 ml of isolation medium
containing increasing concentrations of 10-N-nonyl acridine
orange (NAO; 80–150 μM) [21]. Then, samples were
centrifuged at 10,000× g for 10 min and unbound NAO
was measured in supernatants with a fluorescence spectro-
photometer (Hitachi) (excitation–emission 496–530 nm).
The amount of dyes bound was calculated by subtracting
the amount found in the supernatant from the total added
amount.
2.11 Statistical analysis
Data are presented as mean ± standard error of the
mean (SEM). Statistical analyses were performed by
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using Graph Pad Prism®. Differences between groups
were analysed by non-parametric Mann–Whitney test. Corre-
lations were analysed by Spearman non-parametric test. Dif-
ferences of p<0.05 were considered significant.
3 Results
3.1 Peritoneal carcinosis induces muscle wasting
Muscle loss was evaluated on main hindlimb muscles,
with various compositions in fibre type, as quadriceps
(Quad), extensor digitorum longus (EDL), gastrocnemi-
us (Gast), plantaris (PL), soleus (Sol) and tibialis ante-
rior (TA). There was no effect of calorie restriction per
se (PF rats vs Hal rats) on the six muscle weights
(Table 2). All muscles but slow oxidative soleus had a
significant weight reduction (from 7 to 10 %) in PC rats
compared to PF rats (Table 2).
3.2 Muscle loss is due to fibre atrophy and is related
to an up-regulation of ubiquitin–proteasome-related genes
Gene expression of MuRF1 and MAFbx in quadriceps was
largely significantly increased in PC rats compared to PF
and Hal rats (Fig. 1). Analysis of fibre type composition and
CSA in quadriceps muscle demonstrated a significant re-
duction in fibre CSA in PC rats in comparison to PF rats
(Fig. 2). PC rats had a significant increase in proportion of
fibres with CSA of 500 to 1,000 μm and 1,000 to 1,500 μm
(6- and 2-fold increase, respectively) in comparison to PF
rats. In contrast, the percentage of larger fibres (>5,500 μm)
was lower in PC rats than in PF rats (5,500 to 6,000 μm—3-
fold with p<0.05 and >6,000 μm—4-fold with p00.055)
(Fig. 2a). Compared to PF rats, the mean CSA area of type
IIa/IIx and IIb fibres in the quadriceps of PC rats was
significantly reduced (−27 and −33 %, respectively;
Fig. 2b).
3.3 Evidences for muscle mitochondria bioenergetics
alterations in cachectic rats
The linear relationship between ATP synthesis rate and
oxygen consumption (ATP/O) was similar between PC
and PF rats (Fig. 3) since the intercept and slope of the
two regression lines were not different. However, the
oxygen consumption at the highest hexokinase concen-
tration (highest ATP synthesis rate) was significantly
lower in PC compared to PF (649±36 and 846±36
Table 2 Hindlimb muscles weight in healthy ad libitum (Hal), pair-fed (PF) and peritoneal carcinosis (PC) rats expressed in milligram of muscle
and in milligram per 100 g of body weight (BW)
Quad EDL TA Sol PL Gast
Hal (mg) 5,692±265 398±38 1,261±43 259±28 559±94 3,149±333
PF (mg) 5,131±561 367±25 1,233±64 248±14 500±39 2,888±164
PC (mg) 4,226±409a,b 309±59a,b 976±101a,b 224±32a,b 418±28a,b 2,471±174a,b
Hal (mg/100 g of BW) 1,538±91 108±13 341±20 70±8 153±24 867±115
PF (mg/100 g of BW) 1,544±94 111±6 372±15 75±5 151±12 874±68
PC (mg/100 g of BW) 1,388±76a,b 103±27b 322±36b 73±6 138±11b 814±55b
Values are the mean of the left and right muscle weights. With Hal (n010), PF (n010) and PC (n010). Values are means ± SEM. Statistical
significance was set at p<0.05
Quad quadriceps, EDL extensor digitorum longus, TA tibialis anterior, Sol soleus, PL plantaris, Gast gastronemius
a Significantly different from Hal































Fig. 1 Proteolysis in quadriceps muscle from peritoneal carcinosis
(PC), pair-fed (PF) and healthy ad libitum (Hal) rats. MuRF1 and
MAFbx gene expression, with PF (n010) and PC (n010). Gene
expression levels were normalised for β-actin mRNA. Values are
means ± SEM. Statistical significance was set at p<0.05. Number sign,
significantly different from PF. Dollar sign, significantly different from
Hal
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natoms/min per mg protein, respectively, p00.004). In
the same way, at the highest oxygen consumption com-
mon to PC and PF rats of the ATP to oxygen consump-
tion relationship, ATP synthesis rate was reduced by
20 % in PC rats compared to PF rats, without reaching
statistically significant difference.
Oxygen consumption of quadriceps mitochondria in
phosphorylating state (state III) and uncoupled state (with
FCCP) was significantly reduced (−20 and −16 %, re-
spectively) in PC rats compared to PF rats (Table 3).
These differences between PC and PF rats were not due
to damages induced by mitochondrial isolation procedure.
In fact, cytochrome c stimulation of oxygen consumption
(in percent) was low and similar in both groups (PC—
8.8±3.5 and PF—7.0±3.4). The oxygen consumption in
non-phosphorylating state (state IV, with oligomycin) in
PC rats was not different from PF rats. Respiratory
control ratio (state III to state IV ratio) of skeletal muscle
mitochondria was not affected by peritoneal carcinosis-
induced cachexia (Table 3). Quadriceps UCP2 gene ex-
pression was 3.7 times higher in PC rats compared to PF
rats. However, UCP3 gene expression was similar be-
tween both groups (Fig. 4).
3.4 Reduction in muscle mitochondrial oxidative capacities
is due to reduction in cytochrome c oxidase activity
Cytochrome c oxidase (complex IV) expression was similar
in PC and PF rats (Fig. 5a, b). The activity of complex IV
was significantly reduced by 30 % in PC rats compared to
PF rats (Fig. 5c). There was a positive significant correlation
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Fig. 3 Efficiency of ATP synthesis in isolated quadriceps mitochondria
from pair-fed (PF) and peritoneal carcinosis (PC) rats. ATP/O: relation-
ship between oxygen consumption and ATP synthesis rate. With PF (n0
10) and PC (n010), ATP synthesis was measured by the addition of
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Fig. 2 Distribution of quadriceps fibres according to cross-sectional
area (CSA) and mean cross-sectional area of type I, IIa/IIx and IIb
fibres in pair-fed (PF) and peritoneal carcinosis (PC) rats. a Distribu-
tion of quadriceps fibres and b mean cross-sectional area. CSA were
determined on approximately 150 fibres in two random fields in PF rats
(n04) and PC rats (n07). Values are means ± SEM. Statistical signif-
icance was set at p<0.05. Number sign, significantly different from PF
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maximal oxygen consumption (uncoupled state) (Fig. 6).
This correlation was the same when complex IV activity
was determined by oxygraphy (with TMPD ascorbate as
substrate, R2 0.8, p00.01, data not shown).
3.5 Lower oxidative capacities are not associated
to cardiolipin content modification
Cardiolipin content in quadriceps mitochondria was similar
in PC and PF rats (respectively, 177±9 vs 182±10 nmol/mg
protein).
4 Discussion
Cancer cachexia is the consequence of a negative energy
balance due to both anorexia and hypermetabolism, result-
ing in a wasting syndrome. Skeletal muscle atrophy is a
main target of cancer cachexia. Direct and indirect eviden-
ces suggested the implication of mitochondrial bioenergetics
disorders in muscle loss during cancer cachexia. Hypotheses
about these bioenergetics disorders are mitochondrial
uncoupling and/or alteration of ATP synthesis rate. There-
fore, the aim of this study was to determine if efficiency of
oxidative phosphorylation is impaired in skeletal muscle
mitochondria in a preclinical model of cancer cachexia in
rats.
We had previously validated the model of cancer induced
by peritoneal carcinosis in BDIX rats [20]. It is a useful
preclinical model in cancer cachexia field because peritone-
al carcinosis is a serious clinical situation with a poor
prognosis that is frequent in several cancer types, such as
ovarian, pancreatic, stomach or colorectal cancers. We have
demonstrated the occurrence of hallmarks of the syndrome:
Table 3 Mitochondrial oxygen consumption in quadriceps of pair-fed
(PF, n010) and peritoneal carcinosis (PC, n010) rats
In natoms/min/
mg of proteins
State III State IV Uncoupled
state
RCR
PF 600±20 137±4 603±18 4.4±0.2
PC 480±20a 124±5 508±25a 3.9±0.2
The measurements were run with succinate as energy substrate. State
III: phosphorylating state was performed in the presence of ADP; state
IV: non-phosphorylating state was obtained after the addition of oligo-
mycin; uncoupled state was determined with the uncoupling reagent
FCCP. The RCR was calculated as state III/state IV. Values are means ±
SEM. Statistical significance was set at p<0.05



























Fig. 4 UCP2 and UCP3 gene expression in isolated quadriceps mito-
chondria from pair-fed (PF) and peritoneal carcinosis (PC) rats. With
PF (n08) and PC (n08). Values are means ± SEM. Statistical signif-






























































Fig. 5 Cytochrome c oxidase (COX) protein expression and activity in
isolated quadriceps mitochondria from pair-fed (PF) and peritoneal
carcinosis (PC) rats. a Western blots of COX protein expression, b
Quantification using Quantity One software (Bio-Rad) of the ratio
COX/VDAC protein expression. With PF (n06) and PC (n06), c
Enzymatic activity of COX. With PF (n04) and PC (n04). Values
are means ± SEM. Statistical significance was set at p<0.05. Number
sign, significantly different from PF
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anorexia, systemic inflammation, white adipose and skeletal
muscle wasting. Furthermore, the use of pair-fed rats dem-
onstrated the presence of a hypermetabolism [20]. The first
step of the present study was to check if the model of
peritoneal carcinosis-induced cachexia in BDIX rats was
presenting the main specific characteristics of muscle wast-
ing described in animal and human studies. Focussing on
main hindlimb muscles as quadriceps (Quad), extensor dig-
itorum longus (EDL), gastrocnemius (Gast), plantaris (PL),
soleus (Sol) and tibialis anterior (TA) that presented various
compositions in fibre type, we found that the soleus was the
only muscle unaffected by peritoneal carcinosis. These
results are in agreement with previous studies reporting
that fast glycolytic muscles are more susceptible to
wasting in cancer cachexia [27]. Muscle wasting in the
present study was associated to a large increase in the expres-
sion of two major genes involved in the ubiquitin–proteasome
system, MuRF1 and MAFbx, in quadriceps PC rats in com-
parison to Hal and PF rats as reported by numerous
studies [4, 6].
Since there was no difference between Hal and PF rats
in muscle weight and proteolysis-related gene expression,
we chose to use PF rats as control for PC rats for the
analysis of the following data. Moreover, the aim of the
present study was to investigate if energy wasting (re-
duction in ATP production efficiency) was occurring in
skeletal muscle mitochondria keeping in mind that it
could contribute to cancer cachexia-related hypermetab-
olism. In this way, the pair-fed group allowed us to
discriminate between the effects of anorexia and hypermetab-
olism related to cancer cachexia on the parameters measured
in this study.
Muscle morphology study indicates that muscle loss ob-
served in rat with peritoneal carcinosis was due to a reduc-
tion in fibre CSA rather that in its number. From these data,
we can conclude that peritoneal carcinosis induction in
BDIX rats reached all characteristics of cancer cachexia,
since in addition to what we described previously [20], there
was a clear muscle atrophy affecting fast-twitch fibres asso-
ciated to large up-regulation of the ubiquitin–proteasome
pathway. Thus, the PROb-BDIX model is a suitable model
to investigate mechanisms involved in cancer cachexia and
specifically to study mitochondrial bioenergetics in quadri-
ceps muscle wasting.
In order to elucidate if there are alterations in energy
production yield in skeletal muscle mitochondria in cancer
cachexia, we performed a complete analysis of mitochon-
drial bioenergetics. Our study is the first investigating the
efficiency of oxidative phosphorylation, in isolated skeletal
muscle mitochondria in a preclinical cancer cachexia model.
The ATP synthesis efficiency was sought by measuring the
relationship between oxygen consumption and ATP synthe-
sis rate (ATP/O). The ATP/O was similar between PC and
PF rats. Therefore, we clearly demonstrated that ATP syn-
thesis efficiency was unchanged in quadricepsmitochondria
in our rat model of cancer cachexia (Fig. 3).
The absence of alteration in oxidative phosphorylation
efficiency in PC rats compared to PF rats is contradictory
with the previously suggested mitochondrial uncoupling (by
UCPs) reported in skeletal muscle [10–12, 14–16]. In our
study, the absence of mitochondrial uncoupling was con-
f i rmed by similar oxygen consumption in non-
phosphorylating state (state IV) in PC rats and PF rats. In
fact, state IV is described as the oxygen consumption nec-
essary to compensate loss of electrochemical gradient, con-
sidered as uncoupling due to proton leak. Moreover,
respiratory control ratio (state III/state IV) of skeletal muscle
mitochondria was not affected by peritoneal carcinosis-
induced cachexia. The absence of uncoupling was concom-
itant with overexpression of UCP2 gene in skeletal muscle
in PC rats compared to PF. Surprisingly, there was no
difference in UCP3 expression. These later data need to be
compared with the study that had designed pair-fed groups
as calorie restriction is well known to increase UCP2 and
UCP3 expression [28, 29]. Since PF rats had a significant
increase of 74 % in UCP3 gene expression in comparison to
Hal rats (data not shown), our study is in agreement with
studies reporting that UCP3 gene expression is related to
calorie intake [10, 11]. As mitochondrial uncoupling is
unlikely, our data clearly questioned the role of UCP2 in
skeletal muscle during cancer cachexia. The physiological
and pathological roles of UCP2 and UCP3 are still a large
subject of debate [30]. However, we can highlight the sug-
gested function of UCP2 as antioxidant defence by reducing
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Fig. 6 Relationship between cytochrome c oxidase activity and
maximal oxygen consumption in uncoupled state in quadriceps isolat-
ed mitochondria. The correlation was tested by non-parametric Spear-
man test
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[31, 32]. To reinforce this potential antioxidant role of
UCP2, we have shown that there was no difference in
quadriceps mitochondrial ROS production in PC and PF
rats (data not shown).
Even though the global analysis (slope and intercept) of
ATP/O indicates no alteration in ATP synthesis efficiency,
some difference come to light. In this way, the oxygen
consumption at the highest hexokinase concentration (high-
est ATP synthesis rate) was significantly lower in PC com-
pared to PF (Fig. 3). In the same way, at the highest oxygen
consumption common to PC and PF rats of ATP/O, ATP
synthesis rate was reduced by 20 % in PC rats compared to
PF rats, without reaching statistically significant difference.
Our data are in agreement with the significant reduction in
skeletal muscle ATP synthesis rate, measured in vivo by 31P
NMR, in mice implanted with Lewis lung carcinoma [15].
This suggests that the reduction in the rate of ATP synthesis
observed in vivo is rather due to a reduction in the respira-
tory chain activity than an alteration of the ATP synthesis
efficiency.
We confirmed the reduction in respiratory chain activity
by performing oxygraphic measurement on isolated mito-
chondria. In fact, quadriceps mitochondrial oxygen con-
sumption in the phosphorylating state and in the
uncoupled state was significantly reduced in PC rats com-
pared to PF rats. These data clearly demonstrate lower
muscle mitochondrial oxidative capacities in PC rats com-
pared to PF suggesting alterations in content and/or activity
of respiratory chain complexes. Because complex IV is one
of the main regulator of oxidative phosphorylations in skel-
etal muscle [33], we measured the activity and protein
content of this respiratory complex. While complex IV
expression was unaffected by cancer cachexia, activity was
significantly decrease in PC compared to PF rats. Such
dysfunctions were reported by Ushmorov and collaborators
[18] with C57BL/6 mice bearing fibrosarcoma MCA-105 as
model of cancer cachexia. These authors demonstrated that
in the phosphorylating state, skeletal muscle mitochondria
from tumour-bearing mice displayed significant reduction in
oxygen consumption at complexes II–III and IV in compar-
ison to control mice. More specifically, as the protocol was
set by Ushmorov and co-workers, the measurement of ‘com-
plexes II–III’ activities was in fact ‘complex II–III–IV’
activities since complex IV is the final electron acceptor of
the respiratory chain. Thus, by reporting around the same
percent of reduction (−20 and −25 %) in the activities of
complexes ‘II–III–IV’ and IV alone, these authors provided
evidence for an alteration in complex IV activity in skeletal
muscle-isolated mitochondria from cachectic animals in
complete accordance with our data. We confirmed the spe-
cific implication of complex IV in oxidative capacities re-
duction with a positive significant correlation between COX
activity and uncoupled state oxygen consumption (Fig. 6).
Among the regulators of complex IV activity, cardioli-
pins, a specific phospholipid class of mitochondrial mem-
branes, have been clearly identified [34]. In the present
study, the cardiolipin content in quadriceps mitochondria
was not affected by cancer cachexia. As oxidative stress was
clearly associated to muscle wasting [3], we cannot exclude
the occurrence of cardiolipin peroxidation that was reported
to affect COX activity [35]. Direct oxidative damages of
complex IV by lipid-derived protein adducts (4-HNE and
MDA) cannot be ruled out since protein oxidative damages
were reported in gastrocnemius muscle in AH-130 Yoshida
hepatoma rat model [3]. However, these authors found ATP
synthase as the only oxidative phosphorylation-related pro-
tein affected by lipid peroxidation by-products. Lastly,
because COX activity is known to be regulated by ATP
[36], we can hypothesise that reduction in COX is due to a
higher allosteric ATP inhibition by modulation of COX
phosphorylation.
A reduced mitochondrial oxidative capacity in muscle
during cancer cachexia is somehow paradoxical since
proteolysis by the ubiquitin–proteasome system is ATP
dependent. In this condition, additional ATP supply is
produced by anaerobic glycolytic energy pathways with
lactate production. Thus, skeletal muscle mitochondrial
alterations could participate significantly to the increase
in plasma lactate concentration supplying the futile Cori
cycle that participate to the increase in whole body
energy needs. Moreover, we can speculate that reduction
in skeletal muscle oxidative capacities could play a sig-
nificant role in (1) lipid droplet accumulation [37] and
(2) insulin resistance [38] that are occurring during cancer
cachexia [1].
5 Conclusion
The PROb-BDIX rat model is suitable to investigate the
mechanisms involved in cancer cachexia and specifically
in muscle wasting and the potential implication of mito-
chondrial bioenergetics alterations. Moreover, this model can
be used to test nutritional and pharmacological strategies to
limit muscle atrophy in cancer cachexia. First, our study
confirms that skeletal muscle mitochondrial bioenergetics
alterations are present in cancer cachexia. The nature of these
alterations is not related to energywasting but to a reduction in
mitochondrial oxidative capacities due to a decrease in com-
plex IV activity. This could be responsible for a reduction in
ATP production in muscle mitochondria without modification
of ATP synthesis efficiency. The present study brings new
pieces in the puzzle of mitochondrial implication in muscle
wasting. The mechanisms implicated in the reduction in mus-
cle mitochondrial complex IVactivity in cachectic rat need to
be fully explored.
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